Skip to main content
. 2020 Nov 13;99(46):e23279. doi: 10.1097/MD.0000000000023279

Table 2.

Meta-analysis of the secondary outcome.

Outcome of interest No. of trials No. of patients PMD [95% CI] P value I2 (%)
Systolic blood pressure at baseline 2 196 0.04 [−0.24, 0.32] .78 0
Systolic blood pressure at 30 min 2 196 −0.39 [−2.43, 1.64] .71 0
Systolic blood pressure at 60 min 2 196 −0.13 [−2.00, 1.75] .89 0
Pulse rate at baseline 2 196 0.20 [−0.24, 0.64] .38 0
Pulse rate at 30 min 2 196 −1.61 [−4.94, 1.71] .34 0
Pulse rate at 60 min 2 196 −1.95 [−5.92, 2.03] .34 0
Respiratory rate at baseline 2 196 0.21 [−0.14, 0.55] .25 0
Respiratory rate at 30 min 2 196 −0.38 [−1.16, 0.41] .35 0
Respiratory rate at 60 min 2 196 −0.18 [−0.60, 0.25] .42 0
O2 saturation at baseline 2 196 0.01 [−0.26, 0.27] .96 0
O2 saturation at 30 min 2 196 −0.00 [−0.27, 0.26] .98 0
O2 saturation at 60 min 2 196 −0.04 [−0.31, 0.22] .74 0